Akso Health Group current report, Q1 FY2019

SEC Filing Summary: Hexindai Inc. (Form 6-K)

Business Context and Reporting Period

This Form 6-K was filed by Hexindai Inc., a foreign private issuer, for the month of January 2019. The report was signed by Zhang Qisen (Johnson), Chief Financial Officer, on January 23, 2019. The registrant's principal executive office is located in Beijing, People's Republic of China. The filing serves to distribute a press release (Exhibit 99.1) to U.S. investors.

Key Financial Metrics

The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a cover sheet referencing an external press release and does not contain embedded financial statements or quantitative data.

Material Changes

The filing text does not provide a clear value regarding material changes versus the prior comparable period. No comparative financial data or operational updates are included in the provided text.

Guidance, Outlook, and Risks

The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The content is limited to the form header, signature block, and an exhibit index listing a press release.

Investor Verification Checklist

  • Verify the content of Exhibit 99.1 (Press Release) to obtain the actual financial or operational news intended for disclosure.
  • Confirm the identity of the registrant; the input metadata mentions "Akso Health Group," but the filing text explicitly identifies the registrant as "Hexindai Inc."
  • Review the full press release for any material events, such as executive changes, strategic partnerships, or regulatory updates, which are not detailed in this cover sheet.